ValiRx plc (LON:VAL – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 0.25 and traded as low as GBX 0.15. ValiRx shares last traded at GBX 0.17, with a volume of 81,020,672 shares changing hands.
ValiRx Trading Up 6.3%
The company’s 50 day simple moving average is GBX 0.17 and its two-hundred day simple moving average is GBX 0.25. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.62 and a quick ratio of 1.27. The company has a market cap of £2.24 million, a PE ratio of -0.31 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings data on Monday, June 22nd. The company reported GBX (0.54) earnings per share for the quarter. ValiRx had a negative return on equity of 70.79% and a negative net margin of 7,115.36%.The company had revenue of GBX 3 million for the quarter. As a group, sell-side analysts anticipate that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
